Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by rgonlyfactsplson May 01, 2012 7:36pm
280 Views
Post# 19859120

RE: Has anyone else tried the math?...

RE: Has anyone else tried the math?...
Pfizer's estimate. Did some additional fact checking as the 6 million cases of canine cancer in U.S. that I sourced for previous post seemed high.
Here is Pfizer's estimate for just the U.S. market (from a 2009 press release):
Pfizer Animal Health estimates 1.2 million new canine cancer cases are reported in the U.S. every year.
So with same assumptions:
1,200,000 new canine cancer cases in U.S. x 1% potential market penetration rate = 12,000 cases x $1,000 per dog = $12,000,000 of potential revenue just from the U.S. market.
The market/revenue opportunity is still impre$$ive!!
rg
Bullboard Posts